Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.本文中所述者為化合物,及含有此種化合物之醫藥組合物,其會調制5-脂氧合酶活化蛋白(FLAP)之活性。亦於本文中所描述者為使用此種FLAP調制劑,單獨與併用其他化合物,以治療呼吸道、心血管及其他白三烯素依賴性或白三烯素所媒介症狀或疾病之方法。